Recast Therapy vs. Book Reading for Developmental Language Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to find better ways to help children with Developmental Language Disorder (DLD), a condition that can lead to lifelong challenges in school and work due to difficulties with grammar. Researchers are testing two treatments: Recast Therapy, which involves repeating sentences with corrections, and Syntax Stories, which use books designed to teach specific sentence structures. Either a professional speech therapist or a trained caregiver will deliver both methods to determine which approach works best under typical conditions. Children who might be a good fit for this trial are those aged 4-9, primarily English-speaking, with a confirmed DLD diagnosis, and who do not have autism or significant sensory-motor or psychiatric issues.
As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could improve language support for children with DLD.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that conversational recasting, a key component of Recast Therapy, is generally effective and usually free of negative side effects. This treatment involves repeating and expanding on children's speech to enhance their language skills. Studies have not identified any safety concerns with this method. However, specific safety data for Recast Therapy remains limited, indicating it is well-tolerated but not extensively studied for negative effects.
Syntax Stories involves reading specially designed books to children to aid their language development. Although specific safety data for Syntax Stories is also lacking, its nature as a storytelling activity suggests it poses minimal safety risks.
Both treatments appear well-tolerated, as they involve natural activities like speaking and reading. While specific safety data is limited, the non-invasive and educational nature of these treatments suggests they are safe for children with developmental language disorder.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative ways to address Developmental Language Disorder (DLD) through Recast Therapy and Syntax Stories. Unlike traditional speech therapy methods, Recast Therapy involves either clinicians or caregivers providing immediate feedback to children by correctly reformulating their speech, which may enhance language learning through active engagement. Syntax Stories, on the other hand, use specially scripted books to target specific syntax improvements, offering a structured yet creative approach to language development. This trial seeks to understand the effectiveness of involving caregivers directly in the therapy process, potentially increasing accessibility and consistency of treatment at home. By comparing these methods, researchers aim to determine the best strategies for improving language skills in children with DLD, potentially offering new avenues for treatment beyond conventional speech therapy.
What evidence suggests that this trial's treatments could be effective for Developmental Language Disorder?
This trial will compare Recast Therapy with Syntax Stories for children with Developmental Language Disorder (DLD). Studies have shown that Recast Therapy, one of the treatments in this trial, effectively helps children improve their grammar. This therapy involves correcting a child's sentence by repeating it correctly, allowing them to learn proper grammar by example. Research suggests that different versions of this therapy can either aid or hinder learning, so customizing the approach for each child is important.
Syntax Stories, another treatment option in this trial, use specially written books to teach sentence structure. Research shows they positively impact language skills. These stories are designed to make learning grammar more engaging. While the benefits are clearer for areas like vocabulary, this method offers a fun way to boost language abilities.12678Are You a Good Fit for This Trial?
This trial is for children aged 4-9 with Developmental Language Disorder (DLD), primarily English-speaking, and without autism or significant sensory-motor or psychiatric disorders. They must have a DLD diagnosis confirmed by specific language tests, hearing within the typical range, and caregivers willing to participate in training.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Children receive recast therapy or illustrated syntax stories provided by clinicians or caregivers over a 10-week period
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Recast Therapy
- Syntax Stories
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Delaware
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
University of Maryland, College Park
Collaborator